title: Bronchial hyper-responsiveness after human cardiopulmonary transplantation.
abstract: 1. Bronchial responsiveness to inhaled methacholine was studied in ten heart-lung transplant (HLT) recipients a mean 10.6 months (range 1.5-28 months) post-HLT and in ten normal subjects. 2. The mean provocation dose of methacholine producing a 20% fall in FEV1 (PD20 FEV1) was significantly lower in the HLT recipients (1.70 +/- 3.96 mg vs 11.55 +/- 3.79 mg; P less than 0.001), as was the mean provocation dose of methacholine producing a 50% fall in specific airway conductance (PD50 sGAW) (0.08 +/- 0.08 mg vs 5.13 +/- 5.47 mg; P less than 0.005). 3. These results establish the presence of significant bronchial hyper-responsiveness to inhaled cholinergic agonists in the transplanted lung.
authors.affiliation: Department of Medicine, Stanford University School of Medicine, California 94305.
authors.forename: A R
authors.initials: AR
authors.lastname: Glanville
authors.forename: C M
authors.initials: CM
authors.lastname: Burke
authors.forename: J
authors.initials: J
authors.lastname: Theodore
authors.forename: J C
authors.initials: JC
authors.lastname: Baldwin
authors.forename: J
authors.initials: J
authors.lastname: Harvey
authors.forename: A
authors.initials: A
authors.lastname: Vankessel
authors.forename: E D
authors.initials: ED
authors.lastname: Robin
mesh_terms: D000280:Administration, Inhalation; D001980:Bronchi / Q000187:drug effects*; D001985:Bronchial Provocation Tests; D004305:Dose-Response Relationship, Drug; D005541:Forced Expiratory Volume; D016027:Heart Transplantation; D006801:Humans; D016040:Lung Transplantation; D008688:Methacholine Compounds / Q000008:administration & dosage
chemical_list: D008688:Methacholine Compounds